Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancer

European Journal of Cancer Prevention

Volumn 8, Issue SUPPL. 1, 1999, Pages

  Stockbrugger R W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; COX 2 inhibitors; Familial adenomatous polyposis; NSAIDs; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC;

ADENOMATOUS POLYP; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER PREVENTION; CARCINOGENESIS; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; NEPHROTOXICITY; NONHUMAN; PRECANCER; PRIORITY JOURNAL;

EID: 0342369370     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199912001-00004     Document Type: Conference Paper

References (23)

1. Gann PH, Manson JE, Glynn RJ et al. (1993). Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85: 1220-4.
2. Giovannucci E, Rimm EB, Stampfer MJ et al. (1994). Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241-6.
3. Giovannucci E, Egan KM, Hunter DJ et al. (1995). Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-14.
4. Jacoby RF, Cole CE, Seibert K et al. (1998). The specific cyclooxygenase-2 inhibitor, celecoxib, causes adenoma regression in the Ape mutant Min mouse model [Abstract]. AACR LB-4.
5. Kawamori T, Rao CV, Seibert K et al. (1998). Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58: 409-12.
6. Kune GA, Kune S, Watson LF (1988). Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne colorectal cancer study. Cancer Res 48: 4399-404.
7. Labayle D, Fischer D, Vielh P et al. (1991). Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101: 635-9.
8. Muscat JE, Stellman SD, Wynder EL (1994). Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer 74: 1847-54.
9. Nugent KP, Farmer KCR, Spigelman AD et al. (1993). Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 80: 1618-19.
10. Oshima M, Dinchuk JE, Kargman SL et al. (1996). Suppression of intestinal polyposis in ape 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-9.
11. Paganini-Hill A, Chao A, Ross RK, Henderson BE (1989). Aspirin use and chronic diseases: a cohort study of the elderly. BMJ 299: 1247-50.
12. Peleg II, Maibach HT, Brown SH, Wilcox CM (1994). Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 154: 394-9.
13. Reddy BS, Maruyama H, Kelloff G (1987). Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res 47: 5340-6.
14. Reddy BS, Rao CV, Rivenson A et al. (1993). Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14: 1493-7.
15. Reddy BS, Rao CV, Seibert K (1996). Evaluation of cyclooxygenase2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56: 4566-9.
16. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S (1991). A hypothesis: nonsteroidal antiinflammatory drugs reduce the incidence of large-bowel cancer. J Nat Cancer Inst 83: 355-8.
17. Spagnesi MT, Tonelli F, Dolara P et al. (1994). Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Gastroenterology 106: 362-6.
18. Suh O, Mettlin C, Petrelli NJ (1993). Aspirin use, cancer, and polyps of the large bowel. Cancer 72: 1171-7.
19. Takayama T, Katsuki S, Takahashi Y et al. (1998). Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339: 1277-84.
20. Thun MJ, Namboodiri MM, Heath CW (1991). Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-6.
21. Thun MJ, Namboodiri MM, Calle EE et al. (1993). Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-7.
22. Waddell WR, Loughry RW (1983). Sulindac for polyposis of the colon. J Surg Oncol 24: 83-7.
23. Waddell WR, Ganser GF, Cerise EJ et al. (1989). Sulindac for polyposis of the colon. Am J Surg 157: 175-9.